To assess the translational efficacy of RLY01, we further employed a patient-derived xenograft (PDX) model of colorectal carcinoma harboring a G12V mutation in KRAS (Supplemental Figure 9G). The gene discussed is KRAS; the disease is colorectal carcinoma.